Ben Gerber to Cost-Benefit Analysis
This is a "connection" page, showing publications Ben Gerber has written about Cost-Benefit Analysis.
Connection Strength
0.139
-
Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum ML, Sharp LK. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health. 2012 Oct 23; 12:891.
Score: 0.085
-
Joshi M, Kim K, Pickard AS, Sharp LK, Gerber BS, Touchette DR. Long-term cost-effectiveness of a mobile health intervention delivered by clinical pharmacists and community health workers for type 2 diabetes management in urban African American and Latinx populations. Am J Health Syst Pharm. 2026 Apr 07; 83(8):423-435.
Score: 0.054